942 studies found for:    glioblastoma
Show Display Options
Rank Status Study
21 Suspended Study With Nelfinavir and Combined Radiochemotherapy for Glioblastoma
Condition: Glioblastoma
Intervention: Drug: nelfinavir
22 Terminated A Study of Intraventricular Liposomal Encapsulated Ara-C (DepoCyt) in Patients With Recurrent Glioblastoma
Conditions: Glioblastoma Multiforme;   Glioma;   Astrocytoma;   Brain Tumor
Intervention: Drug: Intrathecal liposomal Ara-C + Temozolomide
23 Recruiting Amgen 386 for Recurrent Glioblastoma
Condition: Glioblastoma Multiforme
Interventions: Drug: Amgen 386;   Drug: Bevacizumab
24 Completed Study of XL184 (Cabozantinib) in Adults With Glioblastoma Multiforme
Condition: Glioblastoma Multiforme
Intervention: Drug: XL184
25 Completed PTK787/ZK 222584 in Combination With Temozolomide and Radiation in Patients With Glioblastoma Taking Enzyme-Inducing Anti-Epileptic Drugs
Condition: Glioblastoma
Interventions: Drug: PTK787/ZK 222584;   Drug: Temozolomide;   Procedure: Radiation Therapy
26 Not yet recruiting Spatial Analysis and Validation of Glioblastoma on 7 T MRI
Condition: Glioblastoma
Interventions: Device: 7 T MRI;   Procedure: Biopsy
27 Active, not recruiting Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
Conditions: Glioblastoma;   Small Cell Glioblastoma;   Giant Cell Glioblastoma;   Gliosarcoma;   Glioblastoma With Oligodendroglial Component
Interventions: Drug: Rindopepimut (CDX-110) with GM-CSF;   Drug: Temozolomide;   Drug: KLH
28 Recruiting Impact of [11C]-Methionine PET/MRI for Individual Tailoring Postoperative Radiochemotherapy for Glioblastoma Multiforme
Condition: Glioblastoma Multiforme
Intervention: Radiation: Radiochemotherapy
29 Recruiting A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Conditions: Glioblastoma;   Small Cell Glioblastoma;   Giant Cell Glioblastoma;   Gliosarcoma;   Glioblastoma With Oligodendroglial Component;   Recurrent Glioblastoma;   Relapsed Glioblastoma
Interventions: Drug: Bevacizumab;   Drug: Rindopepimut (CDX-110) with GM-CSF;   Drug: KLH
30 Active, not recruiting Imaging Biomarkers of Tissue Microstructure and Vasculature as Predictors of Glioblastoma Multiforme
Condition: Glioblastoma
Intervention: Radiation: Magnetic Resonance Imaging (MRI)
31 Recruiting NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent Glioblastoma
Conditions: Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Recurrent Adult Brain Tumor
Interventions: Biological: Bevacizumab;   Device: NovoTTF-l00A;   Other: Quality of Life Assessment
32 Active, not recruiting A Phase 2 Study of PLX3397 in Patients With Recurrent Glioblastoma
Condition: Recurrent Glioblastoma
Intervention: Drug: PLX3397
33 Terminated
Has Results
Study of Everolimus (RAD001) in Patients With Recurrent Glioblastoma Multiforme (GBM)
Condition: Glioblastoma Multiforme
Interventions: Drug: Everolimus;   Procedure: Surgery
34 Recruiting Stress, Exercise Behavior and Survival in Patients With Newly Diagnosed Glioblastoma and in a Close Partner
Conditions: Neoplasms;   Glioblastoma
Intervention: Other: stress
35 Recruiting Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or Gliosarcoma
Conditions: Giant Cell Glioblastoma;   Glioblastoma;   Gliosarcoma
Interventions: Biological: bevacizumab;   Drug: temozolomide;   Other: laboratory biomarker analysis;   Other: immunohistochemistry staining method;   Genetic: microarray analysis;   Genetic: DNA methylation analysis
36 Completed
Has Results
RT, Temozolomide, and Bevacizumab Followed by Bevacizumab/Everolimus in First-line Treatment of GBM
Condition: Glioblastoma Multiforme
Interventions: Radiation: Radiation therapy;   Drug: Temozolomide;   Drug: Bevacizumab;   Drug: Everolimus
37 Recruiting DNX-2401 With Interferon Gamma (IFN-γ) for Recurrent Glioblastoma or Gliosarcoma Brain Tumors
Conditions: Glioblastoma;   Gliosarcoma
Interventions: Drug: Single intratumoral injection of DNX-2401;   Drug: interferon gamma
38 Completed
Has Results
Post Marketing Surveillance: Newly Diagnosed Glioblastoma Multiforme Treated With Radiotherapy/Temozolomide and Adjuvant Temozolomide (Study P04739)
Condition: Glioblastoma
Interventions: Procedure: Primary surgical treatment;   Radiation: Radiotherapy;   Drug: Temozolomide
39 Recruiting PI/II of Temozolomide & Hypofractionated Radiotherapy in Tx of Supratentorial Glioblastoma Multiform
Conditions: Glioblastoma;   Cancer of Brain and Nervous System;   Glioblastoma Multiforme
Interventions: Drug: Temozolomide;   Procedure: Stereotactic Radiosurgery
40 Recruiting Virus DNX2401 and Temozolomide in Recurrent Glioblastoma
Conditions: Glioblastoma Multiforme;   Recurrent Tumor
Intervention: Procedure: DNX2401 and Temozolomide

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years